Author: Angelo Virgilio Paradiso; Simona De Summa; Daniela Loconsole; Vito Procacci; Anna Sallustio; Francesca Centrone; Nicola Silvestris; Vito Cafagna; Giuseppe De Palma; Antonio Tufaro; Vito Garrisi; Maria Chironna
Title: Clinical meanings of rapid serological assay in patients tested for SARS-Co2 RT-PCR Document date: 2020_4_6
ID: ilxd0ih9_29
Snippet: Our study analyzed theclinical performance of the rapid serological test, Viva-Diag TM and confirmedthe test's limited applicability for the diagnosis of SARS-CoV-2 infection when compared to standard molecular testing. However, this rapid serological test seems to provide important information concerning the immunoreaction of individuals to the infection and, more importantly, it may detect previous exposure to the virus in currently healthy per.....
Document: Our study analyzed theclinical performance of the rapid serological test, Viva-Diag TM and confirmedthe test's limited applicability for the diagnosis of SARS-CoV-2 infection when compared to standard molecular testing. However, this rapid serological test seems to provide important information concerning the immunoreaction of individuals to the infection and, more importantly, it may detect previous exposure to the virus in currently healthy persons. The trial, recently registered in ClinicalTrial.gov (NCT04316728), specifically addresses this issue by planning to investigate the monitoringof seroconversion of COVID-19 IgG/IgM in healthy subjects who may develop COVID-19 related symptoms. 1 1
Search related documents:
Co phrase search for related documents- important information and issue address: 1
- important information and molecular testing: 1, 2
- important information and related symptom: 1
- important information and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- important information provide and molecular testing: 1, 2
- important information provide and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- issue address and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- limited applicability and molecular testing: 1
- limited applicability and SARS infection: 1
- molecular testing and previous exposure: 1
- molecular testing and rapid serological test: 1
- molecular testing and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- previous exposure and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- rapid serological test and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
Co phrase search for related documents, hyperlinks ordered by date